BRAF Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549:BRAF Fusion Variants

Autor Lin, Alex, Rodriguez, Fausto J., Karajannis, Matthias A., Williams, Susan C., Legault, Genevieve, Zagzag, David, Burger, Peter C., Allen, Jeffrey C., Eberhart, Charles G., Bar, Eli E.
Vydáno v J Neuropathol Exp Neurol (2012)

Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas

Autor Karajannis, Matthias A., Legault, Geneviève, Hagiwara, Mari, Ballas, Marc S., Brown, Krysten, Nusbaum, Annette O., Hochman, Tsivia, Goldberg, Judith D., Koch, Kevin M., Golfinos, John G., Roland, J. Thomas, Allen, Jeffrey C.
Vydáno 2012

Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas

Autor Karajannis, Matthias A., Legault, Geneviève, Hagiwara, Mari, Giancotti, Filippo G., Filatov, Alexander, Derman, Anna, Hochman, Tsivia, Goldberg, Judith D., Vega, Emilio, Wisoff, Jeffrey H., Golfinos, John G., Merkelson, Amanda, Roland, J. Thomas, Allen, Jeffrey C.
Vydáno 2014

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01

Autor Perreault, Sébastien, Larouche, Valérie, Tabori, Uri, Hawkin, Cynthia, Lippé, Sarah, Ellezam, Benjamin, Décarie, Jean-Claude, Théoret, Yves, Métras, Marie-Élaine, Sultan, Serge, Cantin, Édith, Routhier, Marie-Ève, Caru, Maxime, Legault, Geneviève, Bouffet, Éric, Lafay-Cousin, Lucie, Hukin, Juliette, Erker, Craig, Jabado, Nada
Vydáno v BMC Cancer (2019)

CTNI-24. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01

Autor Perreault, Sébastien, larouche, Valérie, Tabori, Uri, Hawkins, Cynthia, Lippe, Sarah, Ellezam, Benjamin, Décarie, Jean-Claude, Théoret, Yves, Metras, Marie-Élaine, Sultan, Serge, Cantin, Édith, Routhier, Marie-Ève, Caru, Maxime, Legault, Geneviève, Bouffet, Eric, Lafay-Cousin, Lucie, Hukin, Juliette, Erker, Craig, Jabado, Nada
Vydáno v Neuro Oncol (2020)

LGG-25. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01

Autor Perreault, Sébastien, Larouche, Valérie, Tabori, Uri, Hawkins, Cynthia, Lippé, Sarah, Ellezam, Benjamin, Décarie, Jean-Claude, Théoret, Yves, Métras, Marie-Élaine, Sultan, Serge, Cantin, Édith, Routhier, Marie-Ève, Caru, Maxime, Legault, Geneviève, Bouffet, Eric, Lafay-Cousin, Lucie, Hukin, Juliette, Erker, Craig, Jabado, Nada
Vydáno v Neuro Oncol (2020)

Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas

Autor Karajannis, Matthias A., Legault, Geneviève, Fisher, Michael J., Milla, Sarah S., Cohen, Kenneth J., Wisoff, Jeffrey H., Harter, David H., Goldberg, Judith D., Hochman, Tsivia, Merkelson, Amanda, Bloom, Michael C., Sievert, Angela J., Resnick, Adam C., Dhall, Girish, Jones, David T. W., Korshunov, Andrey, Pfister, Stefan M., Eberhart, Charles G., Zagzag, David, Allen, Jeffrey C.
Vydáno 2014

Canadian Pediatric Neuro-Oncology Standards of Practice

Autor Bennett, Julie, Erker, Craig, Lafay-Cousin, Lucie, Ramaswamy, Vijay, Hukin, Juliette, Vanan, Magimairajan I., Cheng, Sylvia, Coltin, Hallie, Fonseca, Adriana, Johnston, Donna, Lo, Andrea, Zelcer, Shayna, Alvi, Saima, Bowes, Lynette, Brossard, Josée, Charlebois, Janie, Eisenstat, David, Felton, Kathleen, Fleming, Adam, Jabado, Nada, Larouche, Valérie, Legault, Geneviève, Mpofu, Chris, Perreault, Sébastien, Silva, Mariana, Sinha, Roona, Strother, Doug, Tsang, Derek S., Wilson, Beverly, Crooks, Bruce, Bartels, Ute
Vydáno v Front Oncol (2020)